E-selectin antagonists (Novartis/Glycotech)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameE-selectin antagonists (Novartis/Glycotech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSelectin E inhibitors
TargetsSelectin E
Therapy Area/IndicationsPsoriasisReperfusion InjuryLung Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis AgGlycotech Corp
Active IndicationsN/A
Inactive IndicationsPsoriasisReperfusion InjuryLung Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A